Does the presence of von Willebrand factor in FVIII‐deficient plasma influences the measurement of FVIII inhibitor titres in haemophilia A patients?
Authors:
- 12 May 2014
- journal article
- research article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 37 (1) , 125-132
Abstract
Reliable measurement of FVIII inhibitor is critical in the follow-up of haemophilia A patients. We performed a multicentre study to evaluate whether the presence of von Willebrand factor (VWF) in FVIII-deficient plasma (FVIII-DP) influences FVIII inhibitor titres. Six French haematology laboratories participated in this study. Three samples with varying FVIII inhibitor titres (1, 5 and 15 BU/mL) and one sample without any detectable FVIII inhibitor were tested using four different procedures for FVIII inhibitor assay. The Nijmegen method and a modified assay with imidazole were performed using FVIII-DP with and without VWF in the control mixture and as substrate plasma in the FVIII one stage assay (OSA). Each mixture (reference and test) was incubated for two hours at 37 °C with buffered normal pool plasma. Higher inhibitor titres were measured in 5 and 15 BU/mL samples when assays were performed with the Nijmegen method and FVIII-DP without VWF. When samples were diluted in imidazole buffer, similar inhibitor titres, close to expected values, were measured whether VWF was present in the FVIII-DP or not. The data obtained were also more accurate when residual FVIII activity levels between 40% and 60% were used to calculate inhibitor titres, despite a linear type I reaction kinetics. These results support the hypothesis that reliable FVIII inhibitor titres can be measured without the use of FVIII-DP containing VWF when an imidazole-modified assay is used.Keywords
This publication has 13 references indexed in Scilit:
- Problems and Solutions in Laboratory Testing for HemophiliaSeminars in Thrombosis and Hemostasis, 2013
- External Quality Assessment of Factor VIII Inhibitor AssaysSeminars in Thrombosis and Hemostasis, 2013
- Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivoJournal of Thrombosis and Haemostasis, 2012
- The factor VIII inhibitor assays can be standardized: results of a workshopJournal of Thrombosis and Haemostasis, 2011
- Laboratory Identification of Factor Inhibitors: The Perspective of a Large Tertiary Hemophilia CenterSeminars in Thrombosis and Hemostasis, 2009
- The between-Laboratory Variation of Factor VIII Inhibitor Testing: The Experience of the External Quality Assessment Program of the ECAT FoundationSeminars in Thrombosis and Hemostasis, 2009
- Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIIIHaemophilia, 2001
- Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIIIHaemophilia, 2001
- The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and ReliabilityThrombosis and Haemostasis, 1995
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986